Clinical Trial Update: An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension Phase [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of PENTASA in Chinese patients with left-sided active ulcerative colitis has completed, including a 24-week o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• PENTASA (MESALAMINE)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED